Fda To Release More Clinical Trial Information For Newly Approved Drugs

Laurie McGinley, Washington Post U.S.
Tue, 01/16/2018 - 3:00pm

The agency commissioner says the step could help researchers and the public better understand FDA decisions.

Topics: fda

BING NEWS:

FDA Approves First ALK Inhibitor for Adjuvant Therapy in Early-Stage NSCLC
Alectinib was approved for the treatment of patients with ALK-positive non-small cell lung cancer after surgical resection.
04/18/2024 - 10:40 am | View Link
FDA Approves Alecensa for ALK-Positive NSCLC
The Food and Drug Administration approved ... moment for people newly diagnosed with early-stage ALK-positive lung cancer, who until now, were not able to receive ALK-specific therapy,” said Ken ...
04/17/2024 - 1:00 pm | View Link
Eli Lilly to Ask FDA to Approve Weight Loss Drug for Sleep Apnea
Preliminary clinical trial results showed the obesity drug tirzepatide was highly effective at treating obstructive sleep apnea, according to information sent to investors of the pharmaceutical ...
04/17/2024 - 6:08 am | View Link
Intra-Cellular builds case for depression drug with late-stage trial win
Shares of the biotech rose 25% after a large trial found adding its drug Caplyta onto antidepressant therapy significantly helped people with major depression.
04/16/2024 - 5:11 am | View Link
Novartis reports data from trial of IgA nephropathy treatment
Swiss pharmaceutical company Novartis has published pre-specified interim analysis results from the Phase III APPLAUSE-IgAN clinical trial of Fabhalta (iptacopan) in Immunoglobulin A nephropathy (IgAN ...
04/16/2024 - 12:29 am | View Link
More

MoviesWithButter : Our Sister Site